TorHoerman Law Advocates for Infants in Pivotal Missouri NEC Trial Against Formula Manufacturers
TorHoerman Law Advocates for Infants in Pivotal Missouri NEC Trial Against Formula Manufacturers
ST. LOUIS, July 3, 2024 /PRNewswire/ -- TorHoerman Law is set to begin trial on July 8, 2024, in Missouri state court. The case will focus on allegations that cow milk-based baby formula is linked to necrotizing enterocolitis (NEC), a dangerous condition affecting premature infants.
2024年7月3日圣路易斯 / PRNewswire / - TorHoerman Law将于2024年7月8日在密苏里州法院开始审判。该案将关注关于奶牛奶基婴儿配方与坏死性肠炎（NEC）的联系。这是一种危及早产儿的严重病症。
The case, Margot Gill, on behalf of herself and her minor child R.D. v. Abbott Laboratories, et al., case number 2322-CC01251, will be heard before Judge Michael Noble in Missouri's 22nd Judicial Circuit in the City of St. Louis. The trial is part of a series of bellwether trials, with thousands of similar cases pending and another major trial scheduled in federal multi-district litigation in early 2025.
此案件名为Margot Gill,v. Abbott Laboratories等, 案号2322-CC01251, 将在圣路易市第22巡回审判法院Michael Noble法官主持下审理。本案是一系列标志性诉讼案件的一部分，目前还有数千个类似案件待审理，另一起重大案件定于2025年初在联邦多区域诉讼中审理。该案是针对Abbott Laboratories的惯常控件，与早先针对Mead Johnson & Company的案件不同。这两家公司都曾维护其奶粉的安全。"我们相信证据将清楚地显示这些配方与NEC之间的联系，并强调立即采取行动保护我们最脆弱的人群的必要性。"来自TorHoerman Law的律师Jake Plattenberger和合伙人表示。
This trial follows a prior case in Illinois where a jury awarded $60 million to a plaintiff whose premature infant tragically died from NEC after consuming cow milk-based formula.
此次审判是在伊利诺伊州的一起案件之后进行的，当时陪审团判定原告早产儿因为饮用奶牛奶配方而不幸去世，判决原告赔偿6000万美元。
"As we prepare to present our case, we remain firmly committed to proving that the negligence of formula manufacturers has led to severe suffering and injustice for many families," said attorney Tor Hoerman. "This trial is not just about compensation, but about ensuring such tragedies are prevented in the future."
"在准备提出我们的案件时，我们始终致力于证明配方生产商的过失导致许多家庭经历了严重的痛苦和不公正。这次审判不仅仅是为了赔偿，更是为了确保未来避免这样的悲剧发生。"来自Tor Hoerman的律师表示。
This litigation involves allegations against Abbott Laboratories, contrasting the earlier case against Mead Johnson & Company, LLC. Both companies have historically defended the safety of their formulas.
此次诉讼涉及对Abbott Laboratories的指控，与早期对Mead Johnson & Company的案件相反。这两家公司都曾维护其奶粉的安全。
"We believe the evidence will clearly show the link between these formulas and NEC, and underscore the need for immediate action to protect our most vulnerable," said Jake Plattenberger, attorney & partner at TorHoerman Law.
"我们相信证据将清楚地显示这些配方与NEC之间的联系，并强调立即采取行动保护我们最脆弱的人群的必要性。"来自TorHoerman Law的律师Jake Plattenberger和合伙人表示。
The plaintiffs are supported by attorneys from TorHoerman Law and Stranch Jennings & Garvey PLLC. Defense for Abbott Laboratories includes Winston & Strawn LLP's Chicago office, Kirkland & Ellis LLP's Chicago and Los Angeles offices, and Jones Day's Washington D.C. office, along with local Missouri counsel from HeplerBroom LLC and Thompson Coburn LLP.
原告由来自TorHoerman Law和Stranch Jennings & Garvey PLLC的律师提供支持。Abbott Laboratories的辩护律师包括温斯顿和斯特劳恩LLP的芝加哥办事处、柯克兰和埃利斯LLP的芝加哥和洛杉矶办事处、琼斯戴的华盛顿特区办事处以及HeplerBroom LLC和 Thompson Coburn LLP的当地律师。
The trial, expected to extend through most of July, promises to be a cornerstone case with significant implications for product liability law and neonatal care standards nationwide.
预计审判将在大部分时间内延续到7月底，将成为具有重要意义的案件，对产品责任法和新生儿护理标准的影响将具有重大意义。
SOURCE TorHoerman Law
TorHoerman Law来源